Cargando…

Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering

Tissue engineered vascular grafts hold promise for the creation of functional blood vessels from biodegradable scaffolds. Because the precise mechanisms regulating this process are still under investigation, inducible genetic mouse models are an important and widely used research tool. However, here...

Descripción completa

Detalles Bibliográficos
Autores principales: Blum, Kevin M., Roby, Lauren C., Zbinden, Jacob C., Chang, Yu-Chun, Mirhaidari, Gabriel J. M., Reinhardt, James W., Yi, Tai, Barker, Jenny C., Breuer, Christopher K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044102/
https://www.ncbi.nlm.nih.gov/pubmed/33850181
http://dx.doi.org/10.1038/s41598-021-87006-3
_version_ 1783678414543126528
author Blum, Kevin M.
Roby, Lauren C.
Zbinden, Jacob C.
Chang, Yu-Chun
Mirhaidari, Gabriel J. M.
Reinhardt, James W.
Yi, Tai
Barker, Jenny C.
Breuer, Christopher K.
author_facet Blum, Kevin M.
Roby, Lauren C.
Zbinden, Jacob C.
Chang, Yu-Chun
Mirhaidari, Gabriel J. M.
Reinhardt, James W.
Yi, Tai
Barker, Jenny C.
Breuer, Christopher K.
author_sort Blum, Kevin M.
collection PubMed
description Tissue engineered vascular grafts hold promise for the creation of functional blood vessels from biodegradable scaffolds. Because the precise mechanisms regulating this process are still under investigation, inducible genetic mouse models are an important and widely used research tool. However, here we describe the importance of challenging the baseline assumption that tamoxifen is inert when used as a small molecule inducer in the context of cardiovascular tissue engineering. Employing a standard inferior vena cava vascular interposition graft model in C57BL/6 mice, we discovered differences in the immunologic response between control and tamoxifen-treated animals, including occlusion rate, macrophage infiltration and phenotype, the extent of foreign body giant cell development, and collagen deposition. Further, differences were noted between untreated males and females. Our findings demonstrate that the host-response to materials commonly used in cardiovascular tissue engineering is sex-specific and critically impacted by exposure to tamoxifen, necessitating careful model selection and interpretation of results.
format Online
Article
Text
id pubmed-8044102
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80441022021-04-14 Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering Blum, Kevin M. Roby, Lauren C. Zbinden, Jacob C. Chang, Yu-Chun Mirhaidari, Gabriel J. M. Reinhardt, James W. Yi, Tai Barker, Jenny C. Breuer, Christopher K. Sci Rep Article Tissue engineered vascular grafts hold promise for the creation of functional blood vessels from biodegradable scaffolds. Because the precise mechanisms regulating this process are still under investigation, inducible genetic mouse models are an important and widely used research tool. However, here we describe the importance of challenging the baseline assumption that tamoxifen is inert when used as a small molecule inducer in the context of cardiovascular tissue engineering. Employing a standard inferior vena cava vascular interposition graft model in C57BL/6 mice, we discovered differences in the immunologic response between control and tamoxifen-treated animals, including occlusion rate, macrophage infiltration and phenotype, the extent of foreign body giant cell development, and collagen deposition. Further, differences were noted between untreated males and females. Our findings demonstrate that the host-response to materials commonly used in cardiovascular tissue engineering is sex-specific and critically impacted by exposure to tamoxifen, necessitating careful model selection and interpretation of results. Nature Publishing Group UK 2021-04-13 /pmc/articles/PMC8044102/ /pubmed/33850181 http://dx.doi.org/10.1038/s41598-021-87006-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Blum, Kevin M.
Roby, Lauren C.
Zbinden, Jacob C.
Chang, Yu-Chun
Mirhaidari, Gabriel J. M.
Reinhardt, James W.
Yi, Tai
Barker, Jenny C.
Breuer, Christopher K.
Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
title Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
title_full Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
title_fullStr Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
title_full_unstemmed Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
title_short Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
title_sort sex and tamoxifen confound murine experimental studies in cardiovascular tissue engineering
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044102/
https://www.ncbi.nlm.nih.gov/pubmed/33850181
http://dx.doi.org/10.1038/s41598-021-87006-3
work_keys_str_mv AT blumkevinm sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT robylaurenc sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT zbindenjacobc sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT changyuchun sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT mirhaidarigabrieljm sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT reinhardtjamesw sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT yitai sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT barkerjennyc sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT breuerchristopherk sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering